Skip to main content

Find Clinical Trials

Home
Conditions
NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors

Clinical trial condition

NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors

Explore clinical trials studying NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors trial results

Completed

A Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors

NCT05187858

Conditions: NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors
Locations: Cliniques universitaires Saint-Luc Brussels, Belgium

Amsterdam UMC Amsterdam, Netherlands

Sarah Cannon Research Institute London, United Kingdom

The Christie NHS Foundation Manchester, United Kingdom

View Trial Details